Drugs / Ropivocaine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02334150 | Jun 2013 → Jun 2014 | dystocia | Nanjing Maternity and Child Health Care Hospital | Completed | No outcome recorded |
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT02799797 Background | Jul 2016 → Feb 2018 | — | Cui Xulei | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Ropivocaine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02799797 ↗ |
| Route | Other | “was continuously infused into the epidural space” NCT02334150 ↗ |